Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04041960 · ClinicalTrials.gov registry record · NA
Effects of TBS on Reading in Adult Struggling Readers
A NA study of Developmental Reading Disorder and Dyslexia, Developmental, sponsored by Georgia State University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT04041960 is a NA study of Developmental Reading Disorder and Dyslexia, Developmental that has completed, run by Georgia State University. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04041960, a NA study of Developmental Reading Disorder and Dyslexia, Developmental, has completed, sponsored by Georgia State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to understand how reading is related to brain function. To do this, participants will perform some reading tasks and then have magnetic resonance imaging (MRI) brain scans. Participants will then receive transcranial magnetic stimulation (TMS) to the reading areas of the brain, followed by a second MRI brain scan. This will temporarily activate reading abilities. We want to better understand how the reading system in the brain functions.
Conditions Studied
Interventions
- OTHER Transcranial magnetic stimulation (TMS)
Study Locations (1)
Georgia
- Center for Advanced Brain Imaging - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04041960
The ClinicalTrials.gov registry entry for NCT04041960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgia State University, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Developmental Reading Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial magnetic stimulation (TMS) is the first listed.
NCT04041960 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04041960 about?
NCT04041960 is a clinical study titled "Effects of TBS on Reading in Adult Struggling Readers". The purpose of this project is to understand how reading is related to brain function. To do this, participants will perform some reading tasks and then have magnetic resonance imaging (MRI) brain scans. Participants will then receive transcranial magnetic stimulation (TMS) to the reading areas of t...
What is the current status of trial NCT04041960?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-05-01. Estimated completion is 2021-06-30.
What conditions does trial NCT04041960 study?
This clinical trial studies the following conditions: Developmental Reading Disorder, Dyslexia, Developmental.
What interventions are being tested in trial NCT04041960?
The interventions under investigation include: Transcranial magnetic stimulation (TMS) (OTHER).
Who is sponsoring clinical trial NCT04041960?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04041960 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.